{
 "drug": "Fondaparinux Sodium Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "09/29/2025",
 "dayN": 330,
 "cat": "Hematology",
 "companies": [
  "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "09/29/2025",
   "update_type": "New",
   "initial_posting_date": "09/29/2025",
   "package_ndc": "0781-3465-95",
   "generic_name": "Fondaparinux Sodium Injection",
   "contact_info": "609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "related_info": "Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.",
   "openfda": {
    "application_number": [
     "ANDA206812"
    ],
    "brand_name": [
     "FONDAPARINUX SODIUM"
    ],
    "generic_name": [
     "FONDAPARINUX SODIUM"
    ],
    "manufacturer_name": [
     "Sandoz Inc."
    ],
    "product_ndc": [
     "0781-3465",
     "0781-3443",
     "0781-3454",
     "0781-3476"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "FONDAPARINUX SODIUM"
    ],
    "rxcui": [
     "861356",
     "861360",
     "861363",
     "861365"
    ],
    "spl_id": [
     "3d5a4b69-462b-7e51-e063-6294a90a0721"
    ],
    "spl_set_id": [
     "baa50757-a927-4d56-a933-5d7798fe6ab0"
    ],
    "package_ndc": [
     "0781-3443-94",
     "0781-3443-12",
     "0781-3443-95",
     "0781-3454-94",
     "0781-3454-12",
     "0781-3454-95",
     "0781-3465-94",
     "0781-3465-12",
     "0781-3465-95",
     "0781-3476-94",
     "0781-3476-12",
     "0781-3476-95"
    ],
    "unii": [
     "X0Q6N9USOZ"
    ]
   },
   "update_date": "09/29/2025",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Fondaparinux Sodium, Injection, 7.5 mg/.6 mL (NDC 0781-3465-95)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/29/2025",
   "update_type": "New",
   "initial_posting_date": "09/29/2025",
   "package_ndc": "0781-3443-95",
   "generic_name": "Fondaparinux Sodium Injection",
   "contact_info": "609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "related_info": "Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.",
   "openfda": {
    "application_number": [
     "ANDA206812"
    ],
    "brand_name": [
     "FONDAPARINUX SODIUM"
    ],
    "generic_name": [
     "FONDAPARINUX SODIUM"
    ],
    "manufacturer_name": [
     "Sandoz Inc."
    ],
    "product_ndc": [
     "0781-3443",
     "0781-3454",
     "0781-3465",
     "0781-3476"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "FONDAPARINUX SODIUM"
    ],
    "rxcui": [
     "861356",
     "861360",
     "861363",
     "861365"
    ],
    "spl_id": [
     "3d5a4b69-462b-7e51-e063-6294a90a0721"
    ],
    "spl_set_id": [
     "baa50757-a927-4d56-a933-5d7798fe6ab0"
    ],
    "package_ndc": [
     "0781-3443-94",
     "0781-3443-12",
     "0781-3443-95",
     "0781-3454-94",
     "0781-3454-12",
     "0781-3454-95",
     "0781-3465-94",
     "0781-3465-12",
     "0781-3465-95",
     "0781-3476-94",
     "0781-3476-12",
     "0781-3476-95"
    ],
    "unii": [
     "X0Q6N9USOZ"
    ]
   },
   "update_date": "09/29/2025",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Fondaparinux Sodium, Injection, 2.5 mg/.5 mL (NDC 0781-3443-95)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/29/2025",
   "update_type": "New",
   "initial_posting_date": "09/29/2025",
   "package_ndc": "0781-3476-95",
   "generic_name": "Fondaparinux Sodium Injection",
   "contact_info": "609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "related_info": "Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.",
   "openfda": {
    "application_number": [
     "ANDA206812"
    ],
    "brand_name": [
     "FONDAPARINUX SODIUM"
    ],
    "generic_name": [
     "FONDAPARINUX SODIUM"
    ],
    "manufacturer_name": [
     "Sandoz Inc."
    ],
    "product_ndc": [
     "0781-3476",
     "0781-3443",
     "0781-3454",
     "0781-3465"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "FONDAPARINUX SODIUM"
    ],
    "rxcui": [
     "861356",
     "861360",
     "861363",
     "861365"
    ],
    "spl_id": [
     "3d5a4b69-462b-7e51-e063-6294a90a0721"
    ],
    "spl_set_id": [
     "baa50757-a927-4d56-a933-5d7798fe6ab0"
    ],
    "package_ndc": [
     "0781-3443-94",
     "0781-3443-12",
     "0781-3443-95",
     "0781-3454-94",
     "0781-3454-12",
     "0781-3454-95",
     "0781-3465-94",
     "0781-3465-12",
     "0781-3465-95",
     "0781-3476-94",
     "0781-3476-12",
     "0781-3476-95"
    ],
    "unii": [
     "X0Q6N9USOZ"
    ]
   },
   "update_date": "09/29/2025",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "09/29/2025",
   "update_type": "New",
   "initial_posting_date": "09/29/2025",
   "package_ndc": "0781-3454-95",
   "generic_name": "Fondaparinux Sodium Injection",
   "contact_info": "609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "related_info": "Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.",
   "openfda": {
    "application_number": [
     "ANDA206812"
    ],
    "brand_name": [
     "FONDAPARINUX SODIUM"
    ],
    "generic_name": [
     "FONDAPARINUX SODIUM"
    ],
    "manufacturer_name": [
     "Sandoz Inc."
    ],
    "product_ndc": [
     "0781-3454",
     "0781-3443",
     "0781-3465",
     "0781-3476"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "FONDAPARINUX SODIUM"
    ],
    "rxcui": [
     "861356",
     "861360",
     "861363",
     "861365"
    ],
    "spl_id": [
     "3d5a4b69-462b-7e51-e063-6294a90a0721"
    ],
    "spl_set_id": [
     "baa50757-a927-4d56-a933-5d7798fe6ab0"
    ],
    "package_ndc": [
     "0781-3443-94",
     "0781-3443-12",
     "0781-3443-95",
     "0781-3454-94",
     "0781-3454-12",
     "0781-3454-95",
     "0781-3465-94",
     "0781-3465-12",
     "0781-3465-95",
     "0781-3476-94",
     "0781-3476-12",
     "0781-3476-95"
    ],
    "unii": [
     "X0Q6N9USOZ"
    ]
   },
   "update_date": "09/29/2025",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Fondaparinux Sodium, Injection, 5 mg/.4 mL (NDC 0781-3454-95)",
   "company_name": "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
   "status": "To Be Discontinued"
  }
 ]
}